about
M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensisNasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in miceTowards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyOral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat modelImmune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.Live bacterial vaccines--a review and identification of potential hazards.Alternative routes of mucosal immunization in large animals.Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.A novel, killed-virus nasal vaccinia virus vaccine.Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.Use of attenuated bacteria as delivery vectors for DNA vaccines.tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.Implication of nanoparticles/microparticles in mucosal vaccine delivery.Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice.Mucosal vaccines: novel advances in technology and delivery.Probiotics: multifarious oral vaccine against infectious traumas.Plant-made immunogens and effective delivery strategies.Topical and mucosal liposomes for vaccine delivery.Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men.Noninvasive vaccination against infectious diseases.
P2860
Q27314549-912F4C51-33E9-4096-B10F-18AAA1F05250Q33725145-42B1B121-EC3F-4D5D-BEF0-39AA54D7F06DQ33843895-3BF2022C-7777-4F7C-B837-8B9C36B7D820Q34025527-EE5DE4EF-EAD0-4ACC-8098-5C10800FCDF1Q34199069-4C23253A-E435-4BAB-BC74-F464DA87D287Q34464553-4411D9ED-D9F9-4142-8E2B-EA660C7D62AFQ34607470-EFB6D581-F632-4030-B813-FA0D31048E21Q34974711-20CF8565-5813-46CE-81E9-20F81FEF0146Q35675891-BEC35215-D000-4323-9F1C-5477EEDA7660Q35910851-95DFF9ED-086A-4D45-BAA1-9B9288E74C30Q35913554-4CE8373A-1F7F-46DD-86B6-3196277A2192Q36145803-58059DF0-1C18-4E09-8196-60B0772BAF44Q36373913-7259F517-7964-4E6A-B1AB-03CF61DE7107Q36452370-7B2E9F3F-E23C-4629-8A24-3971E0C891F3Q36656048-19B2CD63-55BC-43FC-8CC7-F2029AC25545Q36728805-5DFBA48B-2093-45D6-9E8E-53B72142C60EQ36747212-DDAE91CE-045B-4ADA-9607-6A850A9F22ACQ36837152-CF7ACE9F-5EB0-45DC-82F1-9A317AEFC248Q37255619-70D4F26E-79FC-493E-B4C4-EBFC6E73EAE4Q37559647-9FE790C7-489E-4A0C-84F4-2A86CA0FBFD9Q37681016-351A3010-B600-4F1F-B7B7-4FC83F3389A9Q37776713-C85405EC-406C-40CB-AFDE-C49F6799B92FQ37848296-119B911B-E86C-4952-A7FF-23626829C5A4Q39182828-4F069597-F781-4D3C-9F00-06F7B3C10158Q52602778-F822E798-8B76-44D4-8F7C-16FEA90786D0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Experience with registered mucosal vaccines.
@en
type
label
Experience with registered mucosal vaccines.
@en
prefLabel
Experience with registered mucosal vaccines.
@en
P2093
P1433
P1476
Experience with registered mucosal vaccines.
@en
P2093
Alois B Lang
Guido Dietrich
Ian C Metcalfe
Jean-François Viret
Monika Griot-Wenk
P304
P356
10.1016/S0264-410X(02)00579-0
P407
P577
2003-01-01T00:00:00Z